What is the appropriate management of digoxin toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Digoxin Toxicity

Administer digoxin-specific antibody fragments (digoxin-Fab) immediately for life-threatening digoxin toxicity, which includes ventricular arrhythmias, progressive bradyarrhythmias, heart block, or hyperkalemia. This is a Class 1 recommendation with strong evidence showing 50-90% response rates and dysrhythmia resolution within 30-45 minutes 1.

Primary Treatment Algorithm

Step 1: Discontinue Digoxin and Assess Severity

  • Immediately stop digoxin in all cases 2
  • Identify life-threatening manifestations:
    • Ventricular tachycardia or ventricular fibrillation
    • Progressive bradyarrhythmias or heart block
    • Hyperkalemia (particularly >5.5 mmol/L in acute toxicity)
    • Serum digoxin >10 ng/mL
    • Ingestion >10 mg in adults or >4 mg in children 2

Critical point: Toxicity can occur at therapeutic serum concentrations (even 1.4 ng/mL), especially with hypokalemia, hypomagnesemia, hypercalcemia, or renal impairment 3. Clinical features trump serum levels in diagnosis.

Step 2: Digoxin-Fab Administration

For life-threatening toxicity: Administer digoxin-Fab without delay—do not wait for confirmatory serum levels 1, 4. Observational data shows 54% survival in cardiac arrest cases treated with digoxin-Fab 1.

Dosing approach:

  • Life-threatening toxicity: Full neutralizing dose based on body load calculation or empiric dosing
  • Non-life-threatening chronic toxicity: Lower doses (40 mg has shown efficacy) 3
  • Response typically occurs within 30-45 minutes 1

Step 3: Manage Specific Arrhythmias

For bradydysrhythmias:

  • Atropine may be reasonable (Class 2b recommendation) 1
  • Temporary pacing may be reasonable but carries 36% complication rate 1
  • Caution: Pacing is temporizing only while awaiting digoxin-Fab effect 1

For ventricular dysrhythmias:

  • Lidocaine or phenytoin may be reasonable as bridge therapy until digoxin-Fab administered (Class 2b) 1
  • Bretylium is no longer manufactured 1

Step 4: Electrolyte Management

Potassium:

  • Maintain serum potassium 4.0-5.5 mmol/L in non-massive overdose 2
  • In massive overdose with hyperkalemia: Do NOT give potassium—this is life-threatening 2
  • Hyperkalemia from massive toxicity requires digoxin-Fab as primary treatment; glucose-insulin may be needed acutely 2
  • Avoid potassium in bradycardia/heart block unless related to supraventricular tachycardia 2

Magnesium:

  • Correct hypomagnesemia as it sensitizes myocardium to digoxin toxicity 2

Step 5: Gastrointestinal Decontamination (Acute Ingestion Only)

Within 30 minutes of presentation:

  • Gastric lavage or emesis if patient alert 2
  • Do NOT induce emesis if obtunded 2

If >2 hours post-ingestion or toxic manifestations present:

  • Avoid gastric manipulation—may trigger vagal episode worsening arrhythmias 2

Activated charcoal:

  • Large doses recommended to prevent absorption and bind digoxin during enterohepatic recirculation 2

What NOT to Do

Do not use extracorporeal removal (hemodialysis, hemofiltration, hemoperfusion, plasmapheresis)—Class 3 recommendation due to digoxin's large volume of distribution 1. Exception: Hemoperfusion may be considered in renal insufficiency to enhance elimination 5.

Common Pitfalls

  1. Relying solely on serum digoxin levels: Toxicity occurs at therapeutic levels with electrolyte abnormalities or renal impairment 3, 6

  2. Giving potassium in massive overdose: Causes life-threatening hyperkalemia from intracellular potassium shift 2

  3. Delaying digoxin-Fab for confirmatory testing: Treat immediately based on clinical presentation 4

  4. Using calcium in digitalized patients: Rapid IV calcium causes serious arrhythmias 2

  5. Aggressive gastric decontamination after 2 hours: Vagal stimulation worsens arrhythmias 2

Special Populations

Renal impairment: Higher toxicity risk due to prolonged elimination; toxic effects last longer; requires smaller maintenance doses 2

Elderly patients: Account for 88% of toxicity cases; increased susceptibility 7

Acute myocardial infarction: Use digoxin-Fab cautiously as inotropic effects may increase oxygen demand 2

Post-Treatment Monitoring

  • Monitor ECG continuously during treatment
  • Reassess electrolytes frequently, particularly potassium
  • Do not restart digoxin immediately after digoxin-Fab—14% of cases inappropriately received digoxin post-Fab 7
  • Digoxin-Fab effect lasts days; reassess need for digoxin therapy entirely 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.